Nanox Announces Medworks Distribution Agreement for HealthOST AI in Greece

Nanox announced on November 13 that it had appointed Medworks LTD as a nonexclusive reseller of its HealthOST bone-health artificial intelligence software in Greece. The Israeli company said the agreement builds on its existing deployment in Athens and its presence in the Greek market. HealthOST is the initial focus of the arrangement, with the companies able to explore broader cooperation later. Nanox described HealthOST as an FDA-cleared, CE-marked AI solution. Chief executive Erez Meltzer said: “Our agreement with Medworks represents an important step in expanding the commercial reach of Nanox.AI.” Medworks brings local sales, technical support, applications and customer-service capabilities. Its managing director, Tassos Zachos, said the company would support introducing the technology to healthcare providers across Greece and help with adoption. The FDA cleared HealthOST on April 22, 2022. The regulatory record describes software that processes CT images to support clinicians assessing musculoskeletal disease of the spine in patients aged 50 and older. Its functions include labeling vertebrae, measuring vertebral height loss and measuring bone attenuation. The software supplements physicians’ decisions rather than serving as a standalone diagnostic tool.